NSD3::NUTM1 fusion evidenced on RNA sequencing in poorly differentiated thyroid cancer: a report of two cases
We suggest including the search for NUTM1 fusions in the RNA sequencing panel for advanced and refractory thyroid cancers.
Authors
- Laurent Castéra (ORCID: https://orcid.org/0000-0002-0459-3400)
- Virginie Saguet-Rysanek
- Renaud Ciappuccini (ORCID: https://orcid.org/0000-0002-5181-8182)
- Stéphane Bardet (ORCID: https://orcid.org/0000-0002-1881-8674)
- Raphaël Leman (ORCID: https://orcid.org/0000-0003-1978-7133)
- Jacques Balosso (ORCID: https://orcid.org/0000-0003-0714-9003)
- Paul-Antoine Bompain
Institutions
- Inserm (FR)
- Centre François Baclesse (LU)
- Normandie Université (FR)
- Centre François Baclesse (FR)
- Cancers et Préventions (FR)
Publication Details
- Journal
- European Thyroid Journal
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1530/etj-25-0100
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00